Sirius XM Holdings Inc. (NASDAQ:SIRI) was ahead by 1% recently in Tuesday's morning session, boosted by improved financial performance for Q3 ended September 30 that was brought about by strong subscriber growth, tight expense management, and lower subscriber acquisition costs. The radio broadcasting company earned $136 million, or $0.02 per diluted share, on revenues of $1.057 billion during the quarter. The market's call, according to Capital IQ, was for diluted EPS of $0.02 and revenues of $1.042 billion. Last year, net income was $63 million, or $0.01 per diluted share, on revenues of $962 million.CEO Jim Meyer commented: "We are very pleased with the performance of SiriusXM in the third quarter, and we are entering the fourth quarter with tremendous momentum. So far this year we have added nearly 1.2 million subscribers, grown our Adjusted EBITDA margin by more than five percentage points, and increased free cash flow by 32%." With these results, the company is expecting revenues of approximately $4.150 billion for the full-year 2014. Sirius XM Holdings Inc. (NASDAQ:SIRI) is trading within a 52-week range of $2.98 - $3.89.Entegris Inc (NASDAQ:ENTG) Q3 net income topped the Street view while revenue also beat. Q3 net loss was $1.1 million, or $0.01 per diluted share, included amortization of intangible assets of $13.1 million and aggregated acquisition and integration-related costs of $31.2 million associated with the April 30, 2014 acquisition of ATMI, Inc. Non-GAAP net income was $28.8 million, or $0.21 per diluted share, versus the $0.18 per share the Street expected, according to Capital IQ estimates.Entegris Inc (NASDAQ:ENTG), which manufactures materials for the semiconductor industry, reported Q3 sales of $273.1 million, topping the $269 million the Street expected. For Q4, sales guidance is for a range of from $260 million to $275 million, net income of $7 million to $15 million, and net income per diluted share between $0.05 to $0.11 per share. The revenue view is straddling what analysts expect: $268 million in revenue for Q4. On a non-GAAP basis, Q4 EPS is expected to range from $0.15 to $0.21 per diluted share, which reflects net income on a non-GAAP basis in the range of $21 million to $29 million, which is adjusted for expected amortization expense of approximately $13 million, and integration expense of approximately $7 million totaling approximately $20 million or $0.10 per share. The range includes the Street view of $0.18 per share. ENTG trades in a 52-week range of $10.11 to $14.05.Pfizer Inc. (NYSE:PFE) reported Q3 results that topped the analyst consensus on Capital IQ, posting adjusted earnings of $0.57 per share on revenue of $12.36 billion, vs. the Street view of $0.55 per share in earnings on revenue of $12.24 billion. For 2014, Pfizer Inc. (NYSE:PFE) expects revenue of $48.7 to $49.7 billion, narrowing its previous view of $48.7 to $50.7 billion. EPS is seen at $2.23 to $2.27 per share, also narrowing the prior view of $2.20 to $2.30 per share. The Street is at $49.4 billion in revenue and earnings of $2.24 per share.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
